Genomic Signatures of Immune Activation Predict Outcome in Advanced Stages of Ovarian Cancer and Basal-Like Breast Tumors

There is an unmet need for new therapies in metastatic ovarian cancer and basal-like breast cancer since no curative therapies are currently available. Immunotherapy has shown to be active in several solid tumors, but particularly more in those where a pre-activated immune state does exist. In this...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Alcaraz-Sanabria, Ana, Baliu-Piqué, Mariona, Saiz-Ladera, Cristina, Rojas, Katerin, Manzano, Aránzazu, Marquina, Gloria, Casado, Antonio, Cimas, Francisco J., Pérez-Segura, Pedro, Pandiella, Atanasio, Gyorffy, Balázs, Ocana, Alberto
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6965148/
https://ncbi.nlm.nih.gov/pubmed/31998644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.01486
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars